These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

726 related items for PubMed ID: 7655375

  • 1. Isolated extramedullary relapse in children with acute lymphoblastic leukemia: a comparison between treatment results of chemotherapy and bone marrow transplantation. BFM Relapse Study Group.
    Borgmann A, Hartmann R, Schmid H, Klingebiel T, Ebell W, Göbel U, Peters C, Gadner H, Henze G.
    Bone Marrow Transplant; 1995 Apr; 15(4):515-21. PubMed ID: 7655375
    [Abstract] [Full Text] [Related]

  • 2. Allogeneic bone marrow transplantation for a subset of children with acute lymphoblastic leukemia in third remission: a conceivable alternative?
    Borgmann A, Baumgarten E, Schmid H, Dopfer R, Ebell W, Göbel U, Niethammer D, Gadner H, Henze G.
    Bone Marrow Transplant; 1997 Dec; 20(11):939-44. PubMed ID: 9422472
    [Abstract] [Full Text] [Related]

  • 3. Treatment of childhood acute lymphoblastic leukemia after the first relapse: curative strategies.
    Uderzo C, Dini G, Locatelli F, Miniero R, Tamaro P.
    Haematologica; 2000 Nov; 85(11 Suppl):47-53. PubMed ID: 11268324
    [Abstract] [Full Text] [Related]

  • 4. [Allogenic bone marrow transplantation versus autograft in acute lymphoblastic leukemia, in second remission in 113 children. Results of the Grupo Español de Transplante de Medula Niños (GETMON)].
    Badell I, Ortega JJ, Muñoz A, Bureo E, Madero L, Olivé T, Cubells J, Maldonado MS, Baro J, Díaz MA.
    Sangre (Barc); 1996 Apr; 41(2):101-8. PubMed ID: 9045349
    [Abstract] [Full Text] [Related]

  • 5. Allogeneic bone marrow transplantation vs chemotherapy for children with Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Sharathkumar A, Saunders EF, Dror Y, Grant R, Greenberg M, Weitzman S, Chan H, Calderwood S, Freedman MH, Doyle J.
    Bone Marrow Transplant; 2004 Jan; 33(1):39-45. PubMed ID: 14566329
    [Abstract] [Full Text] [Related]

  • 6. Relapsed acute lymphoblastic leukemia: similar outcomes for autologous and allogeneic marrow transplantation in selected children.
    Parsons SK, Castellino SM, Lehmann LE, Eickhoff CE, Tarbell NJ, Sallan SE, Weinstein HJ, Billett AL.
    Bone Marrow Transplant; 1996 May; 17(5):763-8. PubMed ID: 8733695
    [Abstract] [Full Text] [Related]

  • 7. Long-term outcome in children with relapsed ALL by risk-stratified salvage therapy: results of trial acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Münster Group 87.
    Einsiedel HG, von Stackelberg A, Hartmann R, Fengler R, Schrappe M, Janka-Schaub G, Mann G, Hählen K, Göbel U, Klingebiel T, Ludwig WD, Henze G.
    J Clin Oncol; 2005 Nov 01; 23(31):7942-50. PubMed ID: 16258094
    [Abstract] [Full Text] [Related]

  • 8. Bone marrow transplantation in 46 pediatric patients with non-Hodgkin's lymphoma. Spanish Working Party for Bone Marrow Transplantation in Children.
    Bureo E, Ortega JJ, Muñoz A, Cubells J, Madero L, Verdaguer A, Baro J, Olivé T, Maldonado MS, Pardo N.
    Bone Marrow Transplant; 1995 Mar 01; 15(3):353-9. PubMed ID: 7599558
    [Abstract] [Full Text] [Related]

  • 9. Bone marrow transplantation versus prolonged intensive chemotherapy for children with acute lymphoblastic leukemia and an initial bone marrow relapse within 12 months of the completion of primary therapy: Children's Oncology Group study CCG-1941.
    Gaynon PS, Harris RE, Altman AJ, Bostrom BC, Breneman JC, Hawks R, Steele D, Zipf T, Stram DO, Villaluna D, Trigg ME.
    J Clin Oncol; 2006 Jul 01; 24(19):3150-6. PubMed ID: 16717292
    [Abstract] [Full Text] [Related]

  • 10. Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission: factors predictive of survival, relapse and graft-versus-host disease.
    Moussalem M, Esperou Bourdeau H, Devergie A, Baruchel A, Ribaud P, Socie G, Parquet N, Traineau R, Hirsch I, Schaison G.
    Bone Marrow Transplant; 1995 Jun 01; 15(6):943-7. PubMed ID: 7581095
    [Abstract] [Full Text] [Related]

  • 11. Allogeneic bone marrow transplantation vs aggressive post-remission chemotherapy for children with acute myeloid leukemia in first complete remission. A prospective study from the French Society of Pediatric Hematology and Immunology (SHIP).
    Michel G, Leverger G, Leblanc T, Nelken B, Baruchel A, Landman-Parker J, Thuret I, Bergeron C, Bordigoni P, Esperou-Bourdeau H, Perel Y, Vannier JP, Schaison G.
    Bone Marrow Transplant; 1996 Feb 01; 17(2):191-6. PubMed ID: 8640165
    [Abstract] [Full Text] [Related]

  • 12. [Prognosis of children with acute myelocytic leukemia after first relapse].
    Creutzig U, Ritter J, Boos J, Zimmermann M, Bender-Götze C, Stahnke K.
    Klin Padiatr; 1998 Feb 01; 210(4):207-11. PubMed ID: 9743954
    [Abstract] [Full Text] [Related]

  • 13. Autologous bone marrow transplantation for childhood acute lymphoblastic leukemia in remission: first choice for isolated extramedullary relapse?
    Colleselli P, Rossetti F, Messina C, Rondelli R, Dini G, Meloni G, Miniero R, Andolina M, Locatelli F, Amici A.
    Bone Marrow Transplant; 1994 Nov 01; 14(5):821-5. PubMed ID: 7889016
    [Abstract] [Full Text] [Related]

  • 14. High-dose chemotherapy with BEAC regimen and autologous bone marrow transplantation for intermediate grade and immunoblastic lymphoma: durable complete remissions, but a high rate of regimen-related toxicity.
    van Besien K, Tabocoff J, Rodriguez M, Andersson B, Mehra R, Przepiorka D, Dimopoulos M, Giralt S, Suki S, Khouri I.
    Bone Marrow Transplant; 1995 Apr 01; 15(4):549-55. PubMed ID: 7655380
    [Abstract] [Full Text] [Related]

  • 15. Prognostic factors for relapsed childhood acute lymphoblastic leukemia: impact of allogeneic stem cell transplantation--a report from the Kyushu-Yamaguchi Children's Cancer Study Group.
    Matsuzaki A, Nagatoshi Y, Inada H, Nakayama H, Yanai F, Ayukawa H, Kawakami K, Moritake H, Suminoe A, Okamura J.
    Pediatr Blood Cancer; 2005 Aug 01; 45(2):111-20. PubMed ID: 15782402
    [Abstract] [Full Text] [Related]

  • 16. Allogeneic and autologous bone marrow transplantation after consolidation therapy in high-risk acute myeloid leukemia in children. Towards a risk-oriented therapy.
    Ortega JJ, Díaz de Heredia C, Olivé T, Bastida P, Llort A, Armadans L, Torrabadella M, Massuet L.
    Haematologica; 2003 Mar 01; 88(3):290-9. PubMed ID: 12651268
    [Abstract] [Full Text] [Related]

  • 17. Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.
    Harker-Murray PD, Thomas AJ, Wagner JE, Weisdorf D, Luo X, DeFor TE, Verneris MR, Dusenbery KE, MacMillan ML, Tolar J, Baker KS, Orchard PJ.
    Biol Blood Marrow Transplant; 2008 Jun 01; 14(6):685-92. PubMed ID: 18489994
    [Abstract] [Full Text] [Related]

  • 18. [Comparison of chemotherapy alone with allogeneic bone marrow transplantation in first full remission in children with acute myeloid leukemia in the AML-BFM-83 and AML-BFM-87 studies--matched pair analysis].
    Creutzig U, Bender-Götze C, Klingebiel T, Ebell W, Friedrich W, Stollmann-Gibbels B, Schmidt H, Suttorp M, Gratwohl A, Heyen P.
    Klin Padiatr; 1992 Jun 01; 204(4):246-52. PubMed ID: 1518260
    [Abstract] [Full Text] [Related]

  • 19. [Concept and interim result of the ALL-BFM 90 therapy study in treatment of acute lymphoblastic leukemia in children and adolescents: the significance of initial therapy response in blood and bone marrow].
    Schrappe M, Reiter A, Sauter S, Ludwig WD, Wörmann B, Harbott J, Bender-Götze C, Dörffel W, Dopfer R, Frey E.
    Klin Padiatr; 1994 Jun 01; 206(4):208-21. PubMed ID: 7526027
    [Abstract] [Full Text] [Related]

  • 20. Poor outcome for children and adolescents with progressive disease or relapse of lymphoblastic lymphoma: a report from the berlin-frankfurt-muenster group.
    Burkhardt B, Reiter A, Landmann E, Lang P, Lassay L, Dickerhoff R, Lakomek M, Henze G, von Stackelberg A.
    J Clin Oncol; 2009 Jul 10; 27(20):3363-9. PubMed ID: 19433688
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.